Hodgkin's Lymphoma News

• FDA Approves Pembrolizumab for Advanced Merkel Cell Carcinoma With this approval, patients with advanced/metastatic MCC will now have another treatment option.
  Medscape Medical News, December 2018
• After 40 Years, 26% of Pediatric HL Survivors Have a Solid Tumor After pediatric Hodgkin lymphoma, the subsequent risk for a solid tumor goes on and on -- to 40 years and beyond.
  Medscape Medical News, December 2018
• Brentuximab Vedotin and Chemotherapy Effective in Peripheral T-cell Lymphoma Brentuximab vedotin (Adcetris, Seattle Genetics) in combination with chemotherapy is significantly more effective than chemotherapy alone in patients with CD30-positive peripheral T-cell lymphomas, according to the multinational phase 3 ECHELON-2 trial.
  Reuters Health Information, December 2018
• ASH 2018Four Cycles of CHOP Instead of Six for Favorable DLBCL Patients with favorable-prognosis DLBCL receiving four cycles of R-CHOP followed by two additional cycles of rituximab had outcomes similar to those in patients receiving six cycles.
  Medscape Medical News, December 2018
• Alert Approval in 2 Weeks via FDA's New Oncology Drugs Review Approval of a new indication took only 2 weeks with the FDA's new program for reviewing oncology drugs. It involved expanded use of the lymphoma drug brentuximab vedotin.
  FDA Approvals, November 2018
• States Act to Safeguard Young Cancer Patients' Chances to Have Children Some states now require health insurance plans to cover fertility preservation care when medically necessary treatment jeopardizes fertility.
  Kaiser Health News, October 2018
• Eating More Organic Food Tied to Lower Cancer Risk A huge observational study from France surveyed adults online about food consumption and then followed them for a mean of 5 years.
  Medscape Medical News, October 2018
• 'Unexpected': Age 35 Key to Ovarian Function After Chemo for HL Age impacts recovery of ovarian function after chemotherapy for Hodgkin's lymphoma, even when regimens considered less toxic are used.
  Medscape Medical News, October 2018
• Risk of Second Primary Cancer on the Rise in People With HIV
  Reuters Health Information, September 2018
• Czech Beer Is Designed for Cancer Patients' Tastes The nonalcoholic beer has fewer hops, which reduces bitterness, and is diluted with apple juice for sweetening. Clinicians in the Czech Republic, where beer is the national drink, are handing it out to breast cancer patients.
  Medscape Medical News, July 2018
• Young Cancer Survivors at Higher Risk for Endocrine Diseases Adolescent and young adult survivors are at highest risk for thyroid disease, testicular dysfunction, and diabetes. Authors of a large study call for better surveillance of this underserved group.
  Medscape Medical News, July 2018
• EHA 2018First-in-Class Drug Against CD79b Improves Survival in DLBCL The first-in-class antibody-drug conjugate polatuzumab vedotin significantly improved response and overall survival in relapsed or refractory diffuse large B-cell lymphoma.
  Medscape Medical News, June 2018
• EHA 2018Vitamin D Deficiency and Reduced Hodgkin Lymphoma Survival A large study has found that patients with Hodgkin lymphoma who showed baseline deficiencies in vitamin D had significantly shorter progression-free and overall survival.
  Medscape Medical News, June 2018
• Non-AIDS Cancers Expected to Dominate in HIV-infected Adults by 2030
  Reuters Health Information, May 2018
• EU OK for Generic Carmustine for Brain Tumors and Lymphoma A generic version of carmustine has been recommended for approval in the European Union, as have indication extensions for several cancer drugs.
  Medscape Medical News, April 2018
• After 1400% Price Hike, Generic Cancer Drug in Spotlight Skyrocketing prices for some generic drugs have garnered increased attention, and lomustine is the latest to be scrutinized by the federal government
  Medscape Medical News, April 2018
• Alert FDA Approval Tweaks Decades-Old Treatment of Hodgkin's Lymphoma The approval adds to the indications with which brentuximab can used in the treatment of classic Hodgkin's lymphoma.
  FDA Approvals, March 2018
• AACR 2018Successful CAR T-Cell Tx Needs Good T Cells to Begin With Starting with poor-quality T cells may be a key problem in the manufacturing of effective and functional CAR T cells, which may explain why it has been difficult to apply this approach to all cancers.
  Medscape Medical News, March 2018
• For Cancer, Cannabis Has Many Virtues, Says Large Study It's an observational study and cannot demonstrate causality, but new data from Israel indicate that cannabis may improve a range of common symptoms among cancer patients.
  Medscape Medical News, March 2018
• Cancer Survival Unaffected by England's National Cancer Plan Overall short-term cancer survival and socioeconomic inequalities seem to have been unaffected by a 5-year national cancer initiative in England to boost care delivery.
  Medscape Medical News, March 2018